About 10 percent of COVID-19 survivors develop long-term symptoms, leaving them suffering from health problems six months or longer after they’ve been diagnosed.
The study, published April 22, showed that for every 1,000 COVID-19 long-haulers treated at a Veterans Affairs facility, physicians wrote nine more opioid prescriptions than they would have otherwise.
Ziyad Al-Aly, MD, the study’s lead author and research and development chief at VA St. Louis, told Kaiser Health News he is worried that even a small increase of inappropriate opioid prescriptions among COVID-19 long-haulers could lead to an exacerbation of the country’s opioid crisis, since there are millions of Americans currently living with long COVID-19.
The CDC released preliminary data April 14 showing more than 87,000 Americans died from drug overdoses in the 12-month period ending September 2020 — the highest annual death toll recorded since the opioid crisis started in the late 1990s.
More articles on opioids:
California seeks $50B from J&J, Teva, Endo & Allergan for role in opioid epidemic
Biden releases first-year drug policy plan
Overdose deaths jumped 29% in 2020, CDC says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
